ProMIS Neurosciences (PMN) Stock Statistics & Valuation Metrics

ProMIS Neurosciences has a market cap or net worth of $21.87M. The enterprise value is $12.32M.

ProMIS Neurosciences has 53,811,110 shares outstanding. The number of shares has decreased by -2.65% in one year.

ProMIS Neurosciences’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is -100.81%.

The current PE Ratio of ProMIS Neurosciences is ―. ProMIS Neurosciences’s PEG ratio is -0.08.

In the last 12 months, ProMIS Neurosciences had revenue of 0.00 and earned 2.78M in profits. Earnings per share was 2.75.

In the last 12 months, operating cash flow was -27.20M and capital expenditures 0.00, giving a free cash flow of -27.20M billion.

ProMIS Neurosciences pays an annual dividend of ―, resulting in a dividend yield of ―

ProMIS Neurosciences upcoming earnings date is Apr 6, 2026, Before Open (Confirmed).

ProMIS Neurosciences as a current ratio of 8.52, with Debt / Equity ratio of 0.00%

In the past 12 months, ProMIS Neurosciences has paid 0.00 in taxes.

ProMIS Neurosciences EV to EBITDA ratio is 3.95, with an EV/FCF ratio of -0.42.

ProMIS Neurosciences has $15.43M in cash and marketable securities with $0.00 in debt, giving a net cash position of $15.43M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for ProMIS Neurosciences is $8.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy